Safety and efficacy of atrial fibrillation ablation in kidney transplant patients
This study demonstrates that catheter ablation is a viable option for treating AF in kidney transplant patients, with comparable outcomes to non-transplanted individuals. Discontinuing antiarrhythmic drugs reduces drug interaction risks, but minimizing procedural complications remains critical to preserving graft function.
Authors
- Roland Richard Tilz (ORCID: https://orcid.org/0000-0002-0122-7130)
- Martin Nitschke (ORCID: https://orcid.org/0000-0002-2716-7527)
- Lorenzo Bartoli (ORCID: https://orcid.org/0000-0002-8437-0222)
- Thomas Fink (ORCID: https://orcid.org/0000-0002-6665-7326)
- Marcel Feher
- Alessio Gasperetti (ORCID: https://orcid.org/0000-0003-3432-070X)
- Giovanni B. Forleo (ORCID: https://orcid.org/0000-0001-8895-8915)
- Charlotte Eitel (ORCID: https://orcid.org/0000-0002-8733-6791)
- Marco Schiavone (ORCID: https://orcid.org/0000-0003-0720-3380)
- Julia Vogler
- Vanessa Sciacca (ORCID: https://orcid.org/0000-0001-6303-2040)
- Christian-Hendrik H. Heeger (ORCID: https://orcid.org/0000-0002-9014-8097)
- S S Popescu (ORCID: https://orcid.org/0000-0002-5469-8833)
- Huong‐Lan Phan (ORCID: https://orcid.org/0000-0002-6867-914X)
- Anna Traub
- K. Ahmad (ORCID: https://orcid.org/0000-0003-4811-4464)
Institutions
- University of Rome Tor Vergata (IT)
- Johns Hopkins University (US)
- Heart and Diabetes Center North Rhine-Westphalia (DE)
- Asklepios Klinik Altona (DE)
- Luigi Sacco Hospital (IT)
- Centro Cardiologico Monzino (IT)
- IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
- Zentralklinik Bad Berka (DE)
- University Hospital Schleswig-Holstein (DE)
- German Centre for Cardiovascular Research (DE)
- Helios Endo-Klinik Hamburg (DE)
- University of Lübeck (DE)
- University of Bologna (IT)
Publication Details
- Journal
- Journal of Interventional Cardiac Electrophysiology
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1007/s10840-025-02006-x
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Boston Scientific Corporation
- Biosense Webster
- Daiichi Sankyo Europe